Literature DB >> 28347681

Endovascular treatment of ruptured tiny (⩽3mm) intracranial aneurysms in the setting of subarachnoid hemorrhage: A case series of 20 patients and literature review.

Miracle C Anokwute1, John A Braca2, Bradley Bohnstedt3, Andrew DeNardo4, John Scott5, Aaron Cohen-Gadol6, Daniel H Sahlein7.   

Abstract

Successful endovascular coiling of ruptured tiny saccular intracranial aneurysms (⩽3mm) is technically challenging and traditionally has been associated with technical failures, as well as morbidity related to thromboembolic events and high intraoperative rupture rates. This study analyzes the feasibility, technical efficacy, and clinical outcomes of coil embolization of ruptured tiny intracranial aneurysms using current coil and microcatheter technology and techniques. We performed a retrospective review of 20 patients with 20 ruptured tiny aneurysms treated with endovascular coil embolization from 2013 to 2016 at a single high-volume academic tertiary care practice. The mean aneurysm size was 2.4mm (median 2.5mm, 1-3). Complete occlusion was achieved in 12 of 20 patients (60%), the remaining 7 of 20 patients (35%) had a small neck remnant, and there was 1 failure (5%) converted to microsurgical clipping. Two patients had a failed attempted surgical clip reconstruction and were subsequently coiled. There was 1 intraprocedural rupture (5%) and 1 severe parent artery vasospasm (5%) during coiling. At discharge, 60% of patients were living independently. At follow-up three patients were deceased. Mean angiographic follow-up was 139days (SD 120). There were no aneurysm recurrences among occluded patients and there were no retreatments among those with neck remnants. Coiling of ruptured aneurysms ⩽3mm is feasible with high occlusion rates and low complication rates. The availability of softer coils with flexible detachment zones has led to safe and effective endovascular treatment of tiny ruptured aneurysms.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  3mm; Endovascular; Subarachnoid hemorrhage; Tiny ruptured aneurysms

Mesh:

Year:  2017        PMID: 28347681     DOI: 10.1016/j.jocn.2017.01.011

Source DB:  PubMed          Journal:  J Clin Neurosci        ISSN: 0967-5868            Impact factor:   1.961


  6 in total

1.  Discrepancy between two-dimensional and three-dimensional digital subtraction angiography for the planning of endovascular coiling of small cerebral aneurysms <5 mm.

Authors:  Te-Chang Wu; Yu-Kun Tsui; Tai-Yuan Chen; Ching-Chung Ko; Chien-Jen Lin; Jeon-Hor Chen; Ching-Po Lin
Journal:  Interv Neuroradiol       Date:  2020-05-18       Impact factor: 1.610

2.  Endovascular Treatment of Small Ruptured Intracranial Aneurysms (<5 mm) : Long-term Clinical and Angiographic Outcomes and Related Predictors.

Authors:  Fei Peng; Xin Feng; Xin Tong; Baorui Zhang; Luyao Wang; Erkang Guo; Peng Qi; Jun Lu; Zhongxue Wu; Daming Wang; Aihua Liu
Journal:  Clin Neuroradiol       Date:  2019-11-06       Impact factor: 3.649

3.  Independent predictors and risk score for intraprocedural rupture during endovascular treatment of small ruptured intracranial aneurysms (<5 mm).

Authors:  Fei Peng; Xin Feng; Xiaoxin He; Hao Niu; Hong Zhang; Xin Tong; Baorui Zhang; Jiaxiang Xia; Xuge Chen; Boya Xu; Peng Qi; Jun Lu; Daming Wang; Aihua Liu
Journal:  Front Neurol       Date:  2022-08-24       Impact factor: 4.086

Review 4.  White Matter Injury in Early Brain Injury after Subarachnoid Hemorrhage.

Authors:  Jinwei Pang; Jianhua Peng; Ping Yang; Li Kuai; Ligang Chen; John H Zhang; Yong Jiang
Journal:  Cell Transplant       Date:  2018-11-16       Impact factor: 4.064

5.  Endovascular treatment of ruptured tiny aneurysms.

Authors:  Joon Hyuk Kim; Chang Hwa Choi; Jae Il Lee; Tae Hong Lee; Jun Kyeung Ko
Journal:  J Cerebrovasc Endovasc Neurosurg       Date:  2019-06-30

6.  AngioSuite-Assisted Volume Calculation and Coil Use Prediction in the Endovascular Treatment of Tiny Volume Intracranial Aneurysms.

Authors:  Zhihua Du; Bin Lv; Xiangyu Cao; Xinfeng Liu; Rongju Zhang; Hui Su; Jun Wang
Journal:  Biomed Res Int       Date:  2021-07-29       Impact factor: 3.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.